Clinical trial
Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With…
NCT00041574 · Mallinckrodt, Industry · Terminated
Key facts
| NCT number | NCT00041574 |
|---|---|
| Title | Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide |
| Official title | Development of a Hospital-Based Home Program for the Use of Inhaled Nitric Oxide in the Chronic Management of Severe Cardiopulmonary Diseases |
| Lead sponsor | Mallinckrodt, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Hypertension, Lung Disease, Sickle Cell Disease, Cardiac Transplant, Lung Transplant |
| Intervention type | Drug |
| Interventions | Inhaled Nitric Oxide |
| Enrollment | 7 |
| Start date | Apr 1, 2002 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Jul 11, 2002 |
| Last update posted | Sep 9, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: